Sino Biopharmaceutica Company Top Insiders

SBMFF Stock  USD 0.42  0.01  2.33%   
Sino Biopharmaceutica employs about 25.6 K people. The company is managed by 10 executives with a total tenure of roughly 60 years, averaging almost 6.0 years of service per executive, having 2555.2 employees per reported executive. Examination of Sino Biopharmaceutica's management performance can provide insight into the company performance.
Fai Chia  Chairman
Assistant to the Chairman, Personnel Manager
Wun Tse  Chairman
Assistant to the Chairman
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sino Biopharmaceutical Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Sino Biopharmaceutica Management Team Effectiveness

The company has return on total asset (ROA) of 0.0451 % which means that it generated a profit of $0.0451 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2908 %, meaning that it generated $0.2908 on every $100 dollars invested by stockholders. Sino Biopharmaceutica's management efficiency ratios could be used to measure how well Sino Biopharmaceutica manages its routine affairs as well as how well it operates its assets and liabilities.

Sino Biopharmaceutica Workforce Comparison

Sino Biopharmaceutical Limited is currently regarded as top stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 26,846. Sino Biopharmaceutica totals roughly 25,552 in number of employees claiming about 95% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.29 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.

Sino Biopharmaceutical Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Sino Biopharmaceutical Price Series Summation is a cross summation of Sino Biopharmaceutica price series and its benchmark/peer.

Sino Biopharmaceutica Notable Stakeholders

A Sino Biopharmaceutica stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sino Biopharmaceutica often face trade-offs trying to please all of them. Sino Biopharmaceutica's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sino Biopharmaceutica's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Fai ChiaAssistant to the Chairman, Personnel ManagerProfile
Wun TseAssistant to the ChairmanProfile
Y TseExecutive Chairman of the BoardProfile
Wei YeAssistant President Deputy General Manager - R&D DepartmentProfile
Ping TseFounder and President Compliance Officer, Executive Director, Member of Executive Board Committee and Member of Nomination CommitteeProfile
Mingqin LiVice President Director and Deputy General Manager of CTGC and the director of Beijing TideProfile
Zhoushan TianVice President of JCTT and General Manager of NJCTTProfile
Cheung ChengExecutive Director and Member of Executive Board CommitteeProfile
Hsin TseVP, General Manager of Audit Department, Executive Director and Member of Executive Board CommitteeProfile
Eric TseCEO DirectorProfile

About Sino Biopharmaceutica Management Performance

The success or failure of an entity such as Sino Biopharmaceutical often depends on how effective the management is. Sino Biopharmaceutica management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sino management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sino management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutic is traded on OTC Exchange in the United States.

Sino Biopharmaceutica Workforce Analysis

Traditionally, organizations such as Sino Biopharmaceutica use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sino Biopharmaceutica within its industry.

Sino Biopharmaceutica Manpower Efficiency

Return on Sino Biopharmaceutica Manpower

Revenue Per Employee1.1M
Revenue Per Executive2.7B
Net Income Per Employee571.7K
Net Income Per Executive1.5B
Working Capital Per Employee234.7K
Working Capital Per Executive599.8M

Complementary Tools for Sino Pink Sheet analysis

When running Sino Biopharmaceutica's price analysis, check to measure Sino Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sino Biopharmaceutica is operating at the current time. Most of Sino Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sino Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sino Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sino Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume